Hepatitis C: Accurate prediction following non-invasive testing

hepatitis c

Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. In cooperation with researchers from Spain, a research team led by Georg Semmler and Mattias Mandorfer from the Division of Gastroenterology and Hepatology at MedUni Vienna’s Department of Medicine III showed that […]

Read More… from Hepatitis C: Accurate prediction following non-invasive testing

Liver cancer after Hepatitis C: new tool developed

hepatitis

Hepatitis C can now be effectively treated, thanks to modern drugs. However, despite having been cured, some patients can go on to develop liver cancer. Currently, biannual ultrasound screening is done to monitor for incipient cancer. A research team at MedUni Vienna has now developed a new tool that can determine patients’ cancer risk in […]

Read More… from Liver cancer after Hepatitis C: new tool developed

New Hepatitis C cases down by almost 70% in HIV positive men in London & Brighton

New cases of hepatitis C amongst HIV positive men in London and Brighton have fallen by nearly 70 per cent in recent years. An analysis of five clinics in London and Brighton found that 378 cases were diagnosed between July 2013 – June 2018.  New infections peaked at 14 per 1000 people studied in 2015, falling […]

Read More… from New Hepatitis C cases down by almost 70% in HIV positive men in London & Brighton

Going to prison increases HIV transmission risk

If someone is already injecting illegal drugs, going to prison substantially increases the risk that they will acquire HIV or the hepatitis C virus (HCV), according to a new study. New research led by the University of Bristol has found among people who inject drugs, that recent incarceration was associated with an 81 per cent […]

Read More… from Going to prison increases HIV transmission risk

A spotlight on neglected hepatitis

On World Hepatitis Day,  Dr Philippa Matthews, a Wellcome Trust Clinical Research Fellow, puts the spotlight on neglected viruses including hepatitis B and hepatitis C. Some infections are good headline-grabbers – and alongside headlines, come education, engagement, investment, advocacy and action. On the global stage, these diseases include malaria, tuberculosis and HIV, and at home […]

Read More… from A spotlight on neglected hepatitis